How Technology Can Benefit Your Quality Control and Prevent Costly Recalls
Costly recalls can be avoided by integrated the appropriate technologies into the production process.
A Crossroads for the Digital Therapeutics Industry. Now is the Time to Act
Recent events can provide digital therapeutics companies with clear lessons for the future.
When Will Payers Improve Coverage of Prescription Digital Therapeutics?
New MMIT research highlights payers’ continued hesitancy toward PDTs. Here’s what manufacturers need to know.
Cybersecurity Due Diligence Is Now More Important Than Ever
Ensuring due diligence to include cybersecurity is an imperative during any collaboration, partnership or merger.
